Literature DB >> 19894071

Two prolamin peptides from durum wheat preclude celiac disease-specific T cell activation by gluten proteins.

Massimo De Vincenzi1, Olimpia Vincentini, Giovanni Di Nardo, Monica Boirivant, Laura Gazza, Norberto Pogna.   

Abstract

PURPOSE: Celiac disease (CD) is a permanent intolerance to wheat prolamins and related proteins displayed by genetically susceptible individuals. Blocking or modulation of CD-specific T cell response by altered prolamin peptides are currently considered as a potential alternative to the only effective therapy of CD based on a life-long gluten-free diet. Two prolamin peptides, the 9-mer ASRVAPGQQ and the 10-mer GTVGVAPGQQ sequences, were identified by mass spectrometry in the peptic/tryptic digest of prolamins (PTP) from durum wheat (Triticum turgidum ssp. durum) cv. Adamello, and investigated for their ability to preclude the stimulation of CD-specific mucosal T cells by gluten proteins.
METHODS: Gluten-specific polyclonal intestinal T cell lines from five CD children (mean age 5 years) were exposed to 50 microg/ml of a deamidated PTP from whole flour of common wheat (T. aestivum) cv. San Pastore, and tested for proliferation and production of interferon-gamma (INF-gamma) and interleukin 10 (IL-10). The same experiment was performed in the presence of 20 microg/ml of the 9-mer or the 10-mer peptide.
RESULTS: T cells exposed to PTP showed a threefold increase in proliferation and INF-gamma production, and a significant (P <or= 0.05) reduction in IL-10 secretion as compared with control cells incubated with the culture medium. Addition of either the 9-mer or the 10-mer peptide to PTP downregulated T cell proliferation and INF-gamma production, and caused a significant (P <or= 0.05) increase in IL-10 secretion.
CONCLUSIONS: The T cell reactivity elicited by PTP is precluded by both the 9-mer and the 10-mer sequence, suggesting that over-expression of these proteolytically stable peptides may result in a wheat flour with reduced toxicity for CD patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19894071     DOI: 10.1007/s00394-009-0080-4

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  15 in total

1.  Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease.

Authors:  Luigi Maiuri; Carolina Ciacci; Ida Ricciardelli; Loredana Vacca; Valeria Raia; Salvatore Auricchio; Jean Picard; Mohamed Osman; Sonia Quaratino; Marco Londei
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

Review 2.  Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition.

Authors: 
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

3.  Prevention by a decapeptide from durum wheat of in vitro gliadin peptide-induced apoptosis in small-bowel mucosa from coeliac patients.

Authors:  Marco Silano; Fabiana Leonardi; Antonello Trecca; Elena Mancini; Rita Di Benedetto; Massimo De Vincenzi
Journal:  Scand J Gastroenterol       Date:  2007-06       Impact factor: 2.423

4.  A small peptide from durum wheat gliadin prevents cell agglutination induced by prolamin-peptides toxic in coeliac disease.

Authors:  M De Vincenzi; G Gasbarrini; V Silano
Journal:  Toxicology       Date:  1997-07-11       Impact factor: 4.221

5.  A decapeptide from durum wheat prevents celiac peripheral blood lymphocytes from activation by gliadin peptides.

Authors:  Marco Silano; Rita Di Benedetto; Antonello Trecca; Gioacchino Arrabito; Fabiana Leonardi; Massimo De Vincenzi
Journal:  Pediatr Res       Date:  2007-01       Impact factor: 3.756

6.  Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.

Authors:  Lu Shan; Shuo-Wang Qiao; Helene Arentz-Hansen; Øyvind Molberg; Gary M Gray; Ludvig M Sollid; Chaitan Khosla
Journal:  J Proteome Res       Date:  2005 Sep-Oct       Impact factor: 4.466

7.  Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.

Authors:  Alessandra Camarca; Robert P Anderson; Gianfranco Mamone; Olga Fierro; Angelo Facchiano; Susan Costantini; Delia Zanzi; John Sidney; Salvatore Auricchio; Alessandro Sette; Riccardo Troncone; Carmen Gianfrani
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides.

Authors:  Willemijn Vader; Yvonne Kooy; Peter Van Veelen; Arnoud De Ru; Diana Harris; Willemien Benckhuijsen; Salvador Peña; Luisa Mearin; Jan Wouter Drijfhout; Frits Koning
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

9.  Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.

Authors:  Helene Arentz-Hansen; Stephen N McAdam; Øyvind Molberg; Burkhard Fleckenstein; Knut E A Lundin; Thomas J D Jørgensen; Günther Jung; Peter Roepstorff; Ludvig M Sollid
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

10.  A 10-residue peptide from durum wheat promotes a shift from a Th1-type response toward a Th2-type response in celiac disease.

Authors:  Marco Silano; Rita Di Benedetto; Francesca Maialetti; Alessandro De Vincenzi; Roberta Calcaterra; Antonello Trecca; Massimo De Vincenzi
Journal:  Am J Clin Nutr       Date:  2008-02       Impact factor: 7.045

View more
  3 in total

1.  Coeliac disease: immunogenicity studies of barley hordein and rye secalin-derived peptides.

Authors:  Widya A Wahab; Tanja Šuligoj; Julia Ellis; Beatriz Côrtez-Real; Paul J Ciclitira
Journal:  Int J Exp Pathol       Date:  2016-09-23       Impact factor: 1.925

2.  Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease.

Authors:  Barbara Zanini; Beatrice Petroboni; Tarcisio Not; Nicola Di Toro; Vincenzo Villanacci; Francesco Lanzarotto; Norberto Pogna; Chiara Ricci; Alberto Lanzini
Journal:  BMC Gastroenterol       Date:  2013-05-24       Impact factor: 3.067

Review 3.  Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity.

Authors:  Atul Munish Chander; Hariom Yadav; Shalini Jain; Sanjay Kumar Bhadada; Devinder Kumar Dhawan
Journal:  Front Microbiol       Date:  2018-11-01       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.